COCO insider sale notice filed (Form 144)

COCO filed a Form 144 disclosing proposed and recent sales of Common Stock by Martin F. Roper.

Rhea-AI Filing Summary

COCO filed a Form 144 disclosing proposed and recent sales of Common Stock by Martin F. Roper. The filing lists an intended sale of 25,000 shares on 04/24/2026 (option granted 09/19/2019) with cash proceeds. The filing also reports multiple completed dispositions in April 2026, including 25,000 shares for $1,250,000 on 04/07/2026 and other dated sales through 04/16/2026.

Insights

Insider Transactions Analyst

Multiple selling events by Martin F. Roper are disclosed; filings show specific share counts and cash amounts.

The Form 144 entry lists a planned sale of 25,000 shares on 04/24/2026 tied to an option granted on 09/19/2019. Several completed dispositions in early April 2026 are recorded with per‑trade cash proceeds shown.

These notices are regulatory disclosures of sales and do not by themselves indicate corporate action. Subsequent public filings or trading reports will show any market impact.

Key Figures

Planned sale: 25,000 shares Sale on 04/07/2026: 25,000 shares Sale on 04/08/2026: 25,000 shares +5 more

8 metrics

Planned sale 25,000 shares intended sale on 04/24/2026 (option granted 09/19/2019)

Sale on 04/07/2026 25,000 shares proceeds <money>$1,250,000</money>

Sale on 04/08/2026 25,000 shares proceeds <money>$1,273,740.00</money>

Sale on 04/10/2026 25,000 shares proceeds <money>$1,252,680.00</money>

Sale on 04/13/2026 4,456 shares proceeds <money>$225,248.13</money>

Sale on 04/14/2026 25,000 shares proceeds <money>$1,250,000</money>

Sale on 04/15/2026 25,000 shares proceeds <money>$1,252,680.00</money>

Sale on 04/16/2026 25,000 shares proceeds <money>$1,250,000</money>

Key Terms

Form 144, Option Granted, Issuer, Cash proceeds

4 terms

Form 144 regulatory

"Form 144 disclosing proposed and recent sales of Common Stock"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Option Granted financial

"Option Granted 09/19/2019 listed in securities to be sold"

Issuer regulatory

"Entry notes the method as 'Issuer' for the securities to be sold"

Cash proceeds financial

"Sale lines include specific cash proceeds for each disposition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does COCO's Form 144 disclose about Martin F. Roper's sales?

Answer: The Form 144 lists proposed and completed sales by Martin F. Roper, including a planned sale of 25,000 shares on 04/24/2026. Supporting lines show multiple April 2026 dispositions with stated cash proceeds for each trade.

How many shares were reported sold on 04/07/2026 in COCO's filing?

Answer: The filing shows a disposition of 25,000 shares on 04/07/2026 with proceeds of $1,250,000. The entry is listed among other April 2026 transactions by the same reporting person.

Was the 04/24/2026 sale described as an option exercise in the COCO filing?

Answer: The disclosure ties the 04/24/2026 sale to an option granted on 09/19/2019. The method of disposition is labelled as Cash in the filing's securities section.

Do the Form 144 entries state the cash proceeds for each sale?

Answer: Yes. Individual sale lines include cash proceeds, for example $1,250,000 for a 25,000‑share sale on 04/07/2026 and $225,248.13 for a 4,456‑share sale on 04/13/2026.

Does the Form 144 indicate who receives the sale proceeds for COCO transactions?

Answer: The filing shows proceeds amounts tied to each disposition by Martin F. Roper. The entries are reported by the selling person; the filing does not allocate proceeds to other recipients or uses within the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/24/2026 - 04:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001206513
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Vita Coco Company, Inc.
SEC File Number	001-40950
Address of Issuer	111 5TH AVENUE 2ND FLOOR NEW YORK NEW YORK 10003
Phone	212-206-0763
Name of Person for Whose Account the Securities are To Be Sold	Roper Martin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Stree Smithfield RI 02917	25000	1250000.00	57082173	04/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/24/2026	Option Granted 09/19/2019	Issuer			25000	04/24/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Martin F. Roper 111 Fifth Avenue Second Floor New York NY 10003	Common	04/07/2026	25000	1250000.00
Martin F. Roper 111 Fifth Avenue Second Floor New York NY 10003	Common	04/08/2026	25000	1273740.00
Martin F. Roper 111 Fifth Avenue Second Floor New York NY 10003	Common	04/10/2026	25000	1252680.00
Martin F. Roper 111 Fifth Avenue Second Floor New York NY 10003	Common	04/13/2026	4456	225248.13
Martin F. Roper 111 Fifth Avenue Second Floor New York NY 10003	Common	04/14/2026	25000	1250000.00
Martin F. Roper 111 Fifth Avenue Second Floor New York NY 10003	Common	04/15/2026	25000	1252680.00
Martin F. Roper 111 Fifth Avenue Second Floor New York NY 10003	Common	04/16/2026	25000	1250000.00

144: Remarks and Signature

Remarks
Date of Notice	04/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Martin Roper
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)